Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kalaris Therapeutics, Inc.

KLRS Clue Score19

United States Fiscal year ends December CIK 0001754068 Results filed 11 Aug 2026

Add to watchlist

What the insiders did Net buying

Bought (12 mo)

$6.18M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$12.87K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$12.87K

1 of 1 sales

Net

+$6.17M

+$6.17M against sales at will